Fig. 2From: High-dose interleukin2 – a 10-year single-site experience in the treatment of metastatic renal cell carcinoma: careful selection of patients gives an excellent outcomeKaplan –Meier curve showing overall survival (months) of patients with Favourable pathologyBack to article page